| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
INSERM U-402, Faculté de Médecine Saint-Antoine (C.V., C.B., J.C., J.M.); Service dEndocrinologie Pédiatrique, Hôpital Necker-Enfants Malades (J.-J.R.); and Service dEndocrinologie et de Diabétologie, Hôpital Robert Debré (N.T.-R.), Paris, France; Service de Pédiatrie, Hôpital Hôtel-Dieu de France (E.K.), Beirut, Lebanon; Service dEndocrinologie Pédiatrique, Hôpital Sud (M.d.K.), Rennes, France; and CNRS URA 1922, Généthon (S.F., J.W.), Evry, France
Address all correspondence and requests for reprints to: Dr. J. Magré, INSERM U-402, Faculté de Médecine Saint-Antoine, 27 rue Chaligny, 75571 Paris Cedex 12, France. E-mail: magre{at}st-antoine.inserm.fr
Lipoatropic diabetes (LD) is a rare recessive autosomal disorder, mainly characterized by lipoatrophy with alterations in lipid metabolism and extreme insulin resistance. To identify molecular defects responsible for this disease, we tested the implication of 14 candidate genes coding for proteins involved either in insulin action, i.e. insulin receptor, insulin receptor substrate 1, insulin-like growth factor I receptor, diabetes-associated ras-like protein (Rad), and glycogen synthase, or in lipid metabolism, i.e. lipoprotein lipase; apolipoproteins CII, AII, and CIII; hepatic lipase; hormone-sensitive lipase; the ß3-adrenergic receptor; leptin; and fatty acid-binding protein 2. To this end, haplotype and linkage analyses using genotyping with microsatellites in 10 consanguineous families provided us with powerful genetic tools. Our results show that in most families, lod scores at a null recombination fraction were less than -2. Haplotype analysis also argues against the involvement of these genes in LD. This implies that mutations in these genes are unlikely to make a major genetic contribution to LD.
This article has been cited by other articles:
![]() |
J. Magre, M. Delepine, L. Van Maldergem, J.-J. Robert, J. A. Maassen, M. Meier, V. R. Panz, C. A. Kim, N. Tubiana-Rufi, P. Czernichow, et al. Prevalence of Mutations in AGPAT2 Among Human Lipodystrophies Diabetes, June 1, 2003; 52(6): 1573 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. S. Leow, C. L. Addy, and C. S. Mantzoros Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1961 - 1976. [Full Text] [PDF] |
||||
![]() |
P. Fischer, P. Moller, L. Bindl, I. Melzner, H. Tornqvist, K.-M. Debatin, and M. Wabitsch Induction of Adipocyte Differentiation by a Thiazolidinedione in Cultured, Subepidermal, Fibroblast-Like Cells of an Infant with Congenital Generalized Lipodystrophy J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2384 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Andreelli, H. Hanaire-Broutin, M. Laville, J. P. Tauber, J. P. Riou, and C. Thivolet Normal Reproductive Function in Leptin-Deficient Patients with Lipoatropic Diabetes J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 715 - 719. [Abstract] [Full Text] |
||||
![]() |
D. Chen and A. Garg Monogenic disorders of obesity and body fat distribution J. Lipid Res., October 1, 1999; 40(10): 1735 - 1746. [Abstract] [Full Text] |
||||
![]() |
N. A. Tritos and C. S. Mantzoros Syndromes of Severe Insulin Resistance J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3025 - 3030. [Full Text] |
||||
![]() |
V. C. Pardini, I. M. N. Victória, S. M. V. Rocha, D. G. Andrade, A. M. Rocha, F. B. Pieroni, G. Milagres, S. Purisch, and G. Velho Leptin Levels, {beta}-Cell Function, and Insulin Sensitivity in Families with Congenital and Acquired Generalized Lipoatropic Diabetes J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 503 - 508. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |